Articles>> Volume 1 Issue 1, 2017

Biomarkers in cancer diagnosis – Status and challenges
Ashutosh Chauhan
Curr Med Drug Res 1 (1): Art. ID 171 (2017)
Cancer is the second largest disease throughout the world with an increasing mortality over the past few years. This is mainly because of highly heterogeneous in nature and a few effective therapeutic strategies for the treatment. This also represents challenges amongst healthcare professionals and governments. Although a significant advance has been made in cancer treatment, the morbidity and mortality are still enormous. The possibility of detecting cancer at early stages, before it spreads to distant tissues, has been a matter of great interest amongst physicians and scientists because early diagnosis is a key factor for the successful treatment of cancer. To achieve this, we still need of a potential biomarker with significant diagnostic accuracy for cancer.

Related Article

Formulation and evaluation of nanosized aripiprazole-loaded bionanogels using novel bio-retardant from bark of Cinnamomum verum J.Presl
N. V. Satheesh Madhav and Yogita Tyagi
Curr Med Drug Res 1 (1): Art. ID 172 (2017)

Triazines – A comprehensive review of their synthesis and diverse biological importance
Rajeev Kumar, Neeraj Kumar, Ram Kumar Roy and Anita Singh
Curr Med Drug Res 1 (1): Art. ID 173 (2017)

Formulation and evaluation of venlafaxine-loaded bio-flexi film for brain specificity via oro-trans soft palatal route
N. V. Satheesh Madhav, Pranay Kumar and Bhavana Singh
Curr Med Drug Res 1 (1): Art. ID 174 (2017)

Nanoemulsion - An ideal drug delivery for nose-to-brain targeting
Ravindra Semwal
Curr Med Drug Res 1 (1): Art. ID 175 (2017)

Abstracting and Indexing